Primary Site >> Liver Cancer

Gene >> SOCS6

Journal: Tumour Biol. 2012 Feb;33(1):215-21.
Title: SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues.
Author: Yoon, Sungpil|Yi, Young-Su|Kim, Sang Soo|Kim, Ju-Hwa|Park, Won Sang|Nam, Suk Woo
PMID: 22081311
Journal: Mol Cell Biochem. 2013 Jun;378(1-2):99-106.
Title: Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.
Author: Qiu, Xinyu|Zheng, Jianyong|Guo, Xiaodong|Gao, Xingchun|Liu, Hui|Tu, Yanyang|Zhang, Yongsheng
PMID: 23475171
Journal: Tumour Biol. 2014 Nov;35(11):10581-9.
Title: SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.
Author: Kabir, Nuzhat N|Sun, Jianmin|Ronnstrand, Lars|Kazi, Julhash U
PMID: 25172101
Journal: Eur Rev Med Pharmacol Sci. 2015 Sep;19(17):3208-17.
Title: MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.
Author: Li, Z-B|Li, Z-Z|Li, L|Chu, H-T|Jia, M
PMID: 26400524
Journal: Eur Rev Med Pharmacol Sci. 2016 May;20(10):2020-7.
Title: MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1alpha feedback loop.
Author: Wang, X-J|Zhang, D-L|Fu, C|Wei, B-Z|Li, G-J
PMID: 27249600
Journal: J Exp Clin Cancer Res. 2017 Jul 27;36(1):99.
Title: miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
Author: Jiang, Chunlin|Long, Jianting|Liu, Baoxian|Xu, Ming|Wang, Wei|Xie, Xiaoyan|Wang, Xiaolin|Kuang, Ming
PMID: 28750679